Why the study?
What are the biochemical changes in proteases and protease inhibitors in the plasma of patients with pancreatic pseudocysts?
What are the biochemical changes in proteases and protease inhibitors in the plasma of patients with pancreatic pseudocysts?
Biochemical changes in acute pancreatic pseudocysts reflect severe acute pancreatitis, while chronic pseudocysts show ongoing proteolytic activity and pancreatic leakage at convalescence.
Acute pseudocyst protease profiles mirror severe pancreatitis; confirms shared pathophysiology but leaves open distinct formation mechanisms.
A biochemical evaluation was performed on plasma from eight patients developing a pancreatic pseudocyst during acute pancreatitis attacks and from six patients with a known pseudocyst. Patients developing an acute pancreatic pseudocyst had high levels of activated trypsin in complex with alpha 1-protease inhibitor, together with a probable activation of the kinin, complement, coagulation and fibrinolytic systems. Profound changes were also seen in several protease inhibitors, indicating consumption of the inhibitors. The changes did, however, not differ from those seen in severe acute pancreatitis attacks in which no pseudocyst developed. Patients with chronic pancreatic pseudocysts had biochemical changes similar to those seen in moderate pancreatitis attacks, without any overt cascade system activation. At convalescence, however, these patients had biochemical signs of leakage from the pancreas and an ongoing proteolytic activity.
No takes yet. Share an insight, caveat, or question.
Lasson et al. (1987) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: